These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9721331)

  • 1. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS
    Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
    Severina IS
    Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
    Severina IS
    Biull Eksp Biol Med; 1995 Mar; 119(3):230-5. PubMed ID: 7795182
    [No Abstract]   [Full Text] [Related]  

  • 5. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The activation of soluble guanylate cyclase by new NO donors as the basis of a directed search for new efficacious vasodilators and antiaggregants].
    Severina IS; Bussygina OG; Piatakova NV
    Vestn Ross Akad Med Nauk; 2000; (4):25-30. PubMed ID: 10832410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of human platelet aggregation by a new class of soluble guanylate cyclase inhibitor, generating nitric oxide].
    Belushkina NN; Grigor'ev NB; Severina IS
    Biokhimiia; 1994 Nov; 59(11):1689-97. PubMed ID: 7873676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [No: a new look on the mechanism of action of old drugs].
    Severina IS
    Biomed Khim; 2005; 51(1):19-29. PubMed ID: 15850215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties].
    Busygina OG; Belushkina NN; Grigor'ev NB; Severina IS
    Biokhimiia; 1995 Sep; 60(9):1460-7. PubMed ID: 8562654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential alterations in responsiveness in particulate and soluble guanylate cyclases in pregnant guinea pig myometrium.
    Buhimschi IA; San Martin-Clark O; Aguan K; Thompson LP; Weiner CP
    Am J Obstet Gynecol; 2000 Dec; 183(6):1512-9. PubMed ID: 11120520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new class of soluble guanylate cyclase activators, generating nitric oxide].
    Riaposova IK; Grigor'ev NV; Severina IS
    Biokhimiia; 1994 Apr; 59(4):537-42. PubMed ID: 7912551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
    Severina IS
    Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
    Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
    Severina IS; Bussygina OG; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
    Kotikoski H; Kankuri E; Vapaatalo H
    Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
    Severina IS
    Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NO-independent regulatory site on soluble guanylate cyclase.
    Stasch JP; Becker EM; Alonso-Alija C; Apeler H; Dembowsky K; Feurer A; Gerzer R; Minuth T; Perzborn E; Pleiss U; Schröder H; Schroeder W; Stahl E; Steinke W; Straub A; Schramm M
    Nature; 2001 Mar; 410(6825):212-5. PubMed ID: 11242081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide.
    Stone JR; Marletta MA
    Biochemistry; 1996 Jan; 35(4):1093-9. PubMed ID: 8573563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.